| 0000-00-00 |
|
|
|
External link to document |
| 2017-05-09 |
118 |
|
: construction of claims in U.S. Patent No. 8,377,474 (the 474 patent). Signed by Judge Stanley R. Chesler…construction of claims in U.S. Patent No. 8,377,474
(“the ’474 patent”). The Court heard oral argument…intrinsic to the
patent (the patent claims and specifications, along with the patent’s prosecution history…, “Actavis”). In this patent infringement suit involving
pharmaceutical patents, the parties seek construction… It is a bedrock principle of patent law that the claims of a patent define the
invention to |
External link to document |
| 2017-06-08 |
123 |
|
limitations of the asserted claims of U.S.
Patent No. 8,377,474. In the Order, the Court construed, among…U.S. Patent Nos. 8,454,998 and 9,089,607, (which
are in the same patent family as the ‘474 patent and …prejudice all of its counterclaims relating to these patents, Actavis reserves its right to reassert all of … regarding
the disputed limitations of the ‘474 patent claims, Impax hereby stipulates that, without waiving… Application
Number 208522 do not infringe this patent as the claims are construed in the Order.
3. Moreover |
External link to document |
| 2017-06-16 |
127 |
|
regarding the ex parte reexamination of
U.S. patent No. 7,094,427, as ordered in the Court’s Order Granting…following the Patent Trial and Appeal
Board Decision on Appeal. At this time, the Patent Office has not…Motion to Stay Proceedings with respect to the ‘427 patent (D.I. 47). As the Court is aware, on
November 23…2015
25 June 2018
2:15-cv-06934
830 Patent
None
District Court, D. New Jersey |
External link to document |
| 2017-10-24 |
145 |
|
474 patent Ex. 5, U.S. Patent No. 8,377,474
the ’427 patent Ex. 6, U.S. Patent No. 7,094,427 (no…is confirmed by U.S. Patent No.
7,094,427 (“the ’427 patent”). 6 The ’427 patent explains that “[i]nitial…
the ’246 patent Ex. 3, U.S. Patent No. 9,463,246
the ’046 patent Ex. 4, U.S. Patent No. 9,533,…the ’998 patent U.S. Patent No. 8,454,998 (no longer asserted)
the ’607 patent U.S. Patent No. 9,089,607… U.S. Patent Application No. 2007/0148238
patents-in-suit U.S. Patent Nos. 8,557,283; |
External link to document |
| 2017-12-17 |
157 |
|
regarding the ex parte reexamination of
U.S. Patent No. 7,094,427, as ordered in the Court’s Order Granting…with respect to the ‘427 patent (D.I. 47). On November 24, 2017, the U.S.
Patent and Trademark Office issued…Reexamination Certificate
cancelling all claims of the ‘427 patent, and Impax expects that certificate to issue in…formally removing the allegations regarding the ‘427 patent from the case, and expect to file something
next…2015
25 June 2018
2:15-cv-06934
830 Patent
None
District Court, D. New Jersey |
External link to document |
| 2017-12-28 |
162 |
|
brought claims of patent
infringement of U.S. Patent No. 7,094,427 (the “’427 Patent”) against Defendants…U.S. Patent No. 7,094,427.
If the proposed Stipulation of Dismissal Regarding U.S. Patent No. …Certificate cancelling all claims of U.S. Patent No. 7,094,427, enclosed please
find a proposed Stipulation…Stipulation of Dismissal Regarding U.S. Patent No. 7,094,427. Defendants Actavis
Laboratories FL, Inc. and … STIPULATION OF DISMISSAL REGARDING U.S. PATENT NO. 7,094,427
WHEREAS, Plaintiff Impax Laboratories |
External link to document |
